Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study | LANCET ONCOLOGY |